Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cem Akin

Showing results (61-70 of 203) with videos related to

Pageof 21
Sort By:
The Journal of Allergy and Clinical Immunology. in Practice|April 11, 2015
Anaphylaxis after hymenoptera sting: is it venom allergy, a clonal disorder, or both?Mariana C Castells, Jason L Hornick, Cem Akin
European Journal of Haematology|March 11, 2015
Current treatment options in patients with mastocytosis: status in 2015 and future perspectivesMichel Arock, Cem Akin, Olivier Hermine, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 10, 2022
Reply to "Need to define a subgroup of patients with idiopathic mast cell activation syndrome"Theo Gülen, Cem Akin, Dean D Metcalfe, et al.
Journal of the American Academy of Dermatology|March 29, 2003
Assessment of the extent of cutaneous involvement in children and adults with mastocytosis: relationship to symptomatology, tryptase levels, and bone marrow pathologyKnut Brockow, Cem Akin, Mary Huber, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 12, 2022
Recent Developments in the Field of Mast Cell Disorders: Classification, Prognostication, and ManagementPeter Valent, Michel Arock, Cem Akin, et al.
Inflammation & Allergy Drug Targets|April 15, 2006
Current options in the treatment of mast cell mediator-related symptoms in mastocytosisLuis Escribano, Cem Akin, Mariana Castells, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 6, 2026
Reply to "Chronic Spontaneous Urticaria: The Most Common MCAS-Like Disease"Cem Akin, Theo Gülen, Mariana C Castells, et al.
Allergy|January 27, 2023
Legends of Allergy and Immunology-Dean D. MetcalfeCem Akin, Knut Brockow, Karin Hartmann, et al.
Journal of the Advanced Practitioner in Oncology|July 2, 2025
Integrating a Rare Disease into Practice: Development of a Toolkit for Systemic MastocytosisSandra Kurtin, Cem Akin, Tracey I George, et al.
Blood|October 11, 2003
17-Allylamino-17-demethoxygeldanamycin (17-AAG) is effective in down-regulating mutated, constitutively activated KIT protein in human mast cellsGerard Fumo, Cem Akin, Dean D Metcalfe, et al.
Pageof 21

Showing results (61-70 of 203) with videos related to

Sort By:
Pageof 21
The Journal of Allergy and Clinical Immunology. in Practice|April 11, 2015
Anaphylaxis after hymenoptera sting: is it venom allergy, a clonal disorder, or both?Mariana C Castells, Jason L Hornick, Cem Akin
European Journal of Haematology|March 11, 2015
Current treatment options in patients with mastocytosis: status in 2015 and future perspectivesMichel Arock, Cem Akin, Olivier Hermine, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 10, 2022
Reply to "Need to define a subgroup of patients with idiopathic mast cell activation syndrome"Theo Gülen, Cem Akin, Dean D Metcalfe, et al.
Journal of the American Academy of Dermatology|March 29, 2003
Assessment of the extent of cutaneous involvement in children and adults with mastocytosis: relationship to symptomatology, tryptase levels, and bone marrow pathologyKnut Brockow, Cem Akin, Mary Huber, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 12, 2022
Recent Developments in the Field of Mast Cell Disorders: Classification, Prognostication, and ManagementPeter Valent, Michel Arock, Cem Akin, et al.
Inflammation & Allergy Drug Targets|April 15, 2006
Current options in the treatment of mast cell mediator-related symptoms in mastocytosisLuis Escribano, Cem Akin, Mariana Castells, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 6, 2026
Reply to "Chronic Spontaneous Urticaria: The Most Common MCAS-Like Disease"Cem Akin, Theo Gülen, Mariana C Castells, et al.
Allergy|January 27, 2023
Legends of Allergy and Immunology-Dean D. MetcalfeCem Akin, Knut Brockow, Karin Hartmann, et al.
Journal of the Advanced Practitioner in Oncology|July 2, 2025
Integrating a Rare Disease into Practice: Development of a Toolkit for Systemic MastocytosisSandra Kurtin, Cem Akin, Tracey I George, et al.
Blood|October 11, 2003
17-Allylamino-17-demethoxygeldanamycin (17-AAG) is effective in down-regulating mutated, constitutively activated KIT protein in human mast cellsGerard Fumo, Cem Akin, Dean D Metcalfe, et al.
Pageof 21